References
- Bolognia J, Jorizzo JL, Schaffer JL. Disorders of hyperpigmentation. In: Chang MW, ed. Bolognia. 3rd ed. Elsevier; 2012:1057
- Rappersberger K, Hönigsmann H, Ortel B, et al. Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery. J Invest Dermatol 1989;93:201–209
- Gonzalez-Arriagada WA, Silva AR, Vargas PA, et al. Facial pigmentation associated with amiodarone. Gen Dent 2013;61:e15–e17
- Balslev E, Heydenreich G, Jensen SE. [Amiodarone-induced skin pigmentation]. Ugeskr Laeger 1993;155:4014–4015
- Bernstein EF. Q-switched laser treatment of amiodarone pigmentation. J Drugs Dermatol 2011;10:1316–1319
- Jabrocka-Hybel A, Bednarczuk T, Bartalena L, et al. Amiodarone and the thyroid. Endokrynol Pol 2015;66:176–186
- Bahadir S, Apaydin R, Cobanoilu U, et al. Amiodarone pigmentation, eye and thyroid alterations. J Eur Acad Dermatol Venereol 2000;14:194–195
- Erdogan MF, Güleç S, Tutar E, et al. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Thyroid 2003;13:205–209
- Gursoy A, Tutuncu NB, Gencoglu A, et al. Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis. J Natl Med Assoc 2008;100:716–719